Tetrahydromagnolol: Applied Workflows for Peripheral CB2 Res
2026-05-20
Tetrahydromagnolol, a highly selective peripheral CB2 receptor agonist, brings unprecedented precision to cannabinoid receptor research and anti-inflammatory studies. This guide delivers actionable experimental workflows, troubleshooting insights, and protocol enhancements, empowering scientists to unlock advanced applications in GPCR signaling and metastatic models.
Dasatinib Monohydrate: Precision Tool for Personalized Cance
2026-05-20
Dasatinib Monohydrate (BMS-354825) is reshaping cancer research by enabling robust, kinase-targeted assays in advanced assembloid systems. Its multitargeted inhibition profile makes it indispensable for modeling drug resistance and personalizing therapeutic strategies.
Deep Learning Reveals Cardiotoxicity Using iPSC-CMs and High
2026-05-19
This study establishes a scalable, high-content phenotypic screening platform combining deep learning and human iPSC-derived cardiomyocytes to detect drug-induced cardiotoxicity. The approach enables early identification of toxic liabilities in drug development, with implications for optimizing screening of V-ATPase inhibitors and autophagy modulators.
N3-kethoxal: Precision Mapping of RNA & ssDNA in Live Cells
2026-05-19
N3-kethoxal, a membrane-permeable nucleic acid probe, enables selective labeling of unpaired guanines in both RNA and single-stranded DNA, empowering high-resolution mapping of nucleic acid accessibility and interactions. Its azide functionality unlocks rapid, bioorthogonal click chemistry workflows, now validated in the context of immunothrombosis and NET DNA–protein interactions.
Structure-Based Screening Identifies NSP15 Inhibitors for SA
2026-05-18
This study applied a structure-based virtual screening of natural products to identify inhibitors targeting the NSP15 endoribonuclease of SARS-CoV-2. Thymopentin and oleuropein emerged as potent candidates with strong binding and stability, offering new leads for antiviral development and immune modulation strategies.
Distinct Apoptotic Pathways Induced by Candida krusei Forms
2026-05-18
Miao et al. (2023) elucidate how yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) via separate signaling mechanisms. Their findings clarify the molecular basis of fungal mastitis and highlight key roles for mitochondrial and death receptor pathways, as well as TLR2/ERK and JNK/ERK signaling, informing future research into host-pathogen interactions.
MCL-1 Inhibitor A-1210477: Precision Tools for Functional Ca
2026-05-17
Explore how MCL-1 inhibitor A-1210477 empowers mechanistic cancer research through selective mitochondrial apoptosis induction. This article offers practical assay guidance, unique protocol insights, and a critical deep dive into emerging evidence on MCL-1’s anti-apoptotic function.
Urolithin A: Advancing Mitochondrial Biogenesis in Translati
2026-05-16
This thought-leadership article explores the strategic applications of Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) as both a mechanistic probe and a translational tool for mitochondrial quality control, with a particular focus on implications for liver fibrosis and aging. By integrating evidence from recent peer-reviewed studies and workflow-optimized protocols, the discussion provides actionable guidance for translational researchers seeking to address mitochondrial dysfunction, anti-inflammatory effects, and skeletal muscle mitochondrial gene expression modulation. The article further distinguishes itself from standard product pages by contextualizing APExBIO's Urolithin A within the competitive landscape and highlighting its unique role in bridging fundamental and applied research.
Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitor
2026-05-15
Clasto-Lactacystin β-lactone delivers unparalleled specificity as an irreversible, cell-permeable proteasome inhibitor—enabling robust ubiquitin-proteasome pathway research in cancer, neurodegeneration, and viral immunity. This guide translates landmark mechanistic insights and experimental strategies into actionable protocols and troubleshooting tips, maximizing the impact of your proteasome inhibition assays.
WNT5a/GSK3/β-catenin Axis Regulates Adipogenesis in Muscle F
2026-05-15
This study reveals that the WNT5a/GSK3/β-catenin signaling axis critically modulates adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and in vivo approaches, the authors identify GSK3 inhibition and WNT5a signaling as pivotal in restraining fat infiltration in muscle tissue—highlighting potential targets for myopathy intervention.
TMEM16F-Mediated Lipid Scrambling Suppresses Ferroptosis Exe
2026-05-14
Yang et al. reveal that TMEM16F-driven lipid scrambling on the plasma membrane is a critical suppressor of ferroptosis, directly influencing tumor immune rejection. By delineating the membrane remodeling events at the final stage of ferroptotic cell death, the study opens new opportunities for targeted cancer immunotherapy and mechanistic research into regulated cell death.
OSMI-1 and Precision O-GlcNAc Transferase Inhibition: From A
2026-05-14
Explore the scientific depth of OSMI-1, a benchmark O-GlcNAc transferase inhibitor, with a unique focus on assay optimization and mechanistic relevance in O-GlcNAcylation research. Discover new insights for experimental design and translational applications.
Re-evaluating ACE Inhibitor and Aminopeptidase Specificity
2026-05-13
Tieku and Hooper's study systematically compares the inhibitory profiles of bestatin, classic angiotensin converting enzyme (ACE) inhibitors, and other metallopeptidase inhibitors across aminopeptidase N, A, and W. Their findings clarify selectivity gaps critical for cardiovascular and renal disease research, informing the design of more targeted peptidase inhibition protocols.
3-Deazaneplanocin (DZNep): Enabling Precision in Translation
2026-05-13
This article offers a strategic, mechanistic, and evidence-based perspective on the deployment of 3-Deazaneplanocin (DZNep) as both a tool compound and translational lever in oncology. We connect mechanistic insights—the dual targeting of SAHH and EZH2—with experimental design and protocol optimization, while benchmarking DZNep’s value in apoptosis induction, cancer stem cell targeting, and hepatocellular carcinoma research. Drawing on recent literature and advanced workflows, we provide actionable guidance for translational researchers and highlight where this analysis advances beyond traditional product summaries.
3-Aminobenzamide (PARP-IN-1): Bridging Mechanism to Translat
2026-05-12
This thought-leadership article examines the strategic deployment of 3-Aminobenzamide (PARP-IN-1) for translational researchers, integrating mechanistic insights, rigorous protocol parameters, and cross-domain implications for cardiovascular, renal, and virology research. Building from new evidence on PARP-mediated immune modulation, we guide researchers toward impactful, reproducible experimentation with APExBIO’s 3-Aminobenzamide.
459 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page